Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance

With the extensive application of doxorubicin (DOX), DOX resistance has become one of the main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol (RES) were co-encapsulated in a modified PLGA nanoparticle (NPS) to overcome the DOX resistance. CLSM results indic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuan, Huan, Meng-lei, Liu, Miao, Cheng, Ying, Sun, Yang, Cui, Han, Liu, Dao-zhou, Mei, Qi-bing, Zhou, Si-yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059704/
https://www.ncbi.nlm.nih.gov/pubmed/27731405
http://dx.doi.org/10.1038/srep35267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059704/
https://www.ncbi.nlm.nih.gov/pubmed/27731405
http://dx.doi.org/10.1038/srep35267

Ejemplares similares